Sarepta will discontinue its next generation of exon-skipping drugs for Duchenne muscular dystrophy over safety concerns, in ...

Arcus Biosciences ( (RCUS) ) has released its Q3 earnings. Here is a breakdown of the information Arcus Biosciences presented to its investors.

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0401 GMT – The Trump government is likely to still pass the ...

由于众所周知的含金量，减肥药市场已经成为众多生物制药公司抢占的阵地。不但大量资金源源不断地注入了减肥药管线，大小开发商之间似乎也形成了命运共同体，牵一发而动全身的情况不断在减肥药开发领域上演，蝴蝶效应在此表现得异常明显。而且减肥药管线产品之间的相互关 ...